Inovio Pharmaceuticals, Inc. (INO)
1.68
+0.05
(+3.07%)
USD |
NASDAQ |
Mar 17, 16:00
1.69
+0.01
(+0.60%)
After-Hours: 20:00
Inovio Pharmaceuticals EPS Diluted (Quarterly) : 0.0546 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vaxart, Inc. | 0.2289 |
| Stereotaxis, Inc. | -0.061 |
| Capricor Therapeutics, Inc. | -0.6176 |
| Allogene Therapeutics, Inc. | -0.1717 |
| Silvergate Capital Corp. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.765M |
| Total Expenses (Quarterly) | -3.765M |
| Enterprise Value | 66.77M |
| Earnings Yield | -115.1% |
| Normalized Earnings Yield | -113.01 |